(Q35613495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

review article

1 reference

title

Oncolytic herpes viruses as a potential mechanism for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

author name string

Emil Lou

series ordinal

1

1 reference

9 August 2017

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

page(s)

660-671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

Studies on the use of viruses in the treatment of carcinoma of the cervix

16 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Present status of oncolytic virus studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Replication-selective microbiological agents: fighting cancer with targeted germ warfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Newcastle disease virus selectively kills human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Treatment of human cancer with mumps virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Viruses as an aid to cancer therapy: regression of solid and ascites tumors in rodents after treatment with bovine enterovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Adenoviral-mediated gene transfer to mouse salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Clinical research. Gene therapy a suspect in leukemia-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

The Role of Immunosuppression in the Efficacy of Cancer Gene Therapy Using Adenovirus Transfer of the Herpes Simplex Thymidine Kinase Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Engineering herpes simplex virus vectors for CNS applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Replication-defective herpes simplex virus vectors for gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Ganciclovir-induced encephalopathy in a bone marrow transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Safety and efficacy of granulocyte colony-stimulating factor in kidney and liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

A viral inhibitor of peptide transporters for antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Herpes simplex virus turns off the TAP to evade host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

A tale of two trials: selectively replicating herpesviruses for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Treatment of spontaneously arising retinoblastoma tumors in transgenic mice with an attenuated herpes simplex virus mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Oncolytic viral therapy for human prostate cancer by conditionally replicating herpes simplex virus 1 vector G207.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Treatment of Experimental Intracranial Murine Melanoma with a Neuroattenuated Herpes Simplex Virus 1 Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

VIRUSES IN THE TREATMENT OF CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Effects of viruses on tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Viruses as oncolytic agents: a new age for "therapeutic" viruses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

21 January 2018

Measles and leukaemia

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Treatment of human renal cell carcinoma by a conditionally replicating herpes vector G207

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186031000518

21 January 2018

Identifiers

DOI

10.1080/0284186031000518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690152%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference